{
 "context": "The following article called 'BiondVax Pharmaceuticals Ltd. (Nasdaq: BVXV) to Ring The Nasdaq Stock Market Closing Bell' was published on 2015-07-09. The body of the article is as follows:\n    \nDVBS QPSK \nSocial Media: \nFor multimedia features such as exclusive content, photo postings, status updates and video of bell ceremonies please visit our Facebook page at: http://www.facebook.com/NASDAQ . \nFor photos from ceremonies and events visit our Instagram Page: http://instagram.com/nasdaq \nFor news tweets, please visit our Twitter page at: http://twitter.com/nasdaq \nFor exciting viral content and ceremony photos visit Tumblr Page: http://nasdaq.tumblr.com/ \nWebcast: \nA webcast of the Nasdaq Closing Bell will be available at: https://new.livestream.com/nasdaq/live or http://www.nasdaq.com/about/marketsitetowervideo.asx \nPhotos: \nTo obtain a hi-resolution photograph of the Market Close, please go to http://www.nasdaq.com/reference/marketsite_events.stm and click on the market close of your choice. \nAbout BiondVax Pharmaceuticals Ltd. (Nasdaq: BVXV ): \nBiondVax Pharmaceuticals, a publicly-traded company (TASE: BNDX ) (Nasdaq: BVXV ) located in the Weizmann Science Park in Ness-Ziona (Israel), is dedicated to the development of a novel Universal Influenza Vaccine. BiondVax's Universal Flu Vaccine is based on research carried out over a period of 20 years by Weizmann Institute Professor Ruth Arnon, who heads the company's Scientific Advisory Board. Professor Arnon is well-known for her part in the development of Copaxone\u00ae, a blockbuster drug for the treatment of multiple sclerosis. \nAbout Nasdaq: \nNasdaq (Nasdaq: NDAQ ) is a leading provider of trading, clearing, exchange technology, listing, information and public company services across six continents. Through its diverse portfolio of solutions, Nasdaq enables customers to plan, optimize and execute their business vision with confidence, using proven technologies that provide transparency and insight for navigating today's global capital markets. As the creator of the world's first electronic stock market, its technology powers more than 70 marketplaces in 50 countries, and 1 in 10 of the world's securities transactions. Nasdaq is home to more than 3,500 listed companies with a market value of approximately $9.5 trillion and more than 10,000 corporate clients. To learn more, visit: nasdaq.com/ambition or business.nasdaq.com . -NDAQA-\n\n    The day before the article was published, the stock price of BiondVax Pharmaceuticals Ltd. was 4.340000152587891 and the day after the article was published, the stock price of BiondVax Pharmaceuticals Ltd. was ",
 "expected": "4.630000114440918",
 "date": "2015-07-09",
 "ticker": "BVXV",
 "company": "BiondVax Pharmaceuticals Ltd."
}